The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading ->
Growing up in Bangladesh where several infectious diseases transmitted by helminths (worms) take a large health toll, Tilak Chandra Nath has always been fascinated with the challenges of addressing diseases of poverty. During his postgraduate training as a TDR-supported fellow at the Universitas Gadjah Mada (UGM) in Indonesia in 2016, he studied parasitic diseases, focusing […] Continue reading ->